Cargando…

Non-viral Gene Delivery Methods for Bone and Joints

Viral carrier transport efficiency of gene delivery is high, depending on the type of vector. However, viral delivery poses significant safety concerns such as inefficient/unpredictable reprogramming outcomes, genomic integration, as well as unwarranted immune responses and toxicity. Thus, non-viral...

Descripción completa

Detalles Bibliográficos
Autores principales: Gantenbein, Benjamin, Tang, Shirley, Guerrero, Julien, Higuita-Castro, Natalia, Salazar-Puerta, Ana I., Croft, Andreas S., Gazdhar, Amiq, Purmessur, Devina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711090/
https://www.ncbi.nlm.nih.gov/pubmed/33330428
http://dx.doi.org/10.3389/fbioe.2020.598466
_version_ 1783618071321116672
author Gantenbein, Benjamin
Tang, Shirley
Guerrero, Julien
Higuita-Castro, Natalia
Salazar-Puerta, Ana I.
Croft, Andreas S.
Gazdhar, Amiq
Purmessur, Devina
author_facet Gantenbein, Benjamin
Tang, Shirley
Guerrero, Julien
Higuita-Castro, Natalia
Salazar-Puerta, Ana I.
Croft, Andreas S.
Gazdhar, Amiq
Purmessur, Devina
author_sort Gantenbein, Benjamin
collection PubMed
description Viral carrier transport efficiency of gene delivery is high, depending on the type of vector. However, viral delivery poses significant safety concerns such as inefficient/unpredictable reprogramming outcomes, genomic integration, as well as unwarranted immune responses and toxicity. Thus, non-viral gene delivery methods are more feasible for translation as these allow safer delivery of genes and can modulate gene expression transiently both in vivo, ex vivo, and in vitro. Based on current studies, the efficiency of these technologies appears to be more limited, but they are appealing for clinical translation. This review presents a summary of recent advancements in orthopedics, where primarily bone and joints from the musculoskeletal apparatus were targeted. In connective tissues, which are known to have a poor healing capacity, and have a relatively low cell-density, i.e., articular cartilage, bone, and the intervertebral disk (IVD) several approaches have recently been undertaken. We provide a brief overview of the existing technologies, using nano-spheres/engineered vesicles, lipofection, and in vivo electroporation. Here, delivery for microRNA (miRNA), and silencing RNA (siRNA) and DNA plasmids will be discussed. Recent studies will be summarized that aimed to improve regeneration of these tissues, involving the delivery of bone morphogenic proteins (BMPs), such as BMP2 for improvement of bone healing. For articular cartilage/osteochondral junction, non-viral methods concentrate on targeted delivery to chondrocytes or MSCs for tissue engineering-based approaches. For the IVD, growth factors such as GDF5 or GDF6 or developmental transcription factors such as Brachyury or FOXF1 seem to be of high clinical interest. However, the most efficient method of gene transfer is still elusive, as several preclinical studies have reported many different non-viral methods and clinical translation of these techniques still needs to be validated. Here we discuss the non-viral methods applied for bone and joint and propose methods that can be promising in clinical use.
format Online
Article
Text
id pubmed-7711090
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77110902020-12-15 Non-viral Gene Delivery Methods for Bone and Joints Gantenbein, Benjamin Tang, Shirley Guerrero, Julien Higuita-Castro, Natalia Salazar-Puerta, Ana I. Croft, Andreas S. Gazdhar, Amiq Purmessur, Devina Front Bioeng Biotechnol Bioengineering and Biotechnology Viral carrier transport efficiency of gene delivery is high, depending on the type of vector. However, viral delivery poses significant safety concerns such as inefficient/unpredictable reprogramming outcomes, genomic integration, as well as unwarranted immune responses and toxicity. Thus, non-viral gene delivery methods are more feasible for translation as these allow safer delivery of genes and can modulate gene expression transiently both in vivo, ex vivo, and in vitro. Based on current studies, the efficiency of these technologies appears to be more limited, but they are appealing for clinical translation. This review presents a summary of recent advancements in orthopedics, where primarily bone and joints from the musculoskeletal apparatus were targeted. In connective tissues, which are known to have a poor healing capacity, and have a relatively low cell-density, i.e., articular cartilage, bone, and the intervertebral disk (IVD) several approaches have recently been undertaken. We provide a brief overview of the existing technologies, using nano-spheres/engineered vesicles, lipofection, and in vivo electroporation. Here, delivery for microRNA (miRNA), and silencing RNA (siRNA) and DNA plasmids will be discussed. Recent studies will be summarized that aimed to improve regeneration of these tissues, involving the delivery of bone morphogenic proteins (BMPs), such as BMP2 for improvement of bone healing. For articular cartilage/osteochondral junction, non-viral methods concentrate on targeted delivery to chondrocytes or MSCs for tissue engineering-based approaches. For the IVD, growth factors such as GDF5 or GDF6 or developmental transcription factors such as Brachyury or FOXF1 seem to be of high clinical interest. However, the most efficient method of gene transfer is still elusive, as several preclinical studies have reported many different non-viral methods and clinical translation of these techniques still needs to be validated. Here we discuss the non-viral methods applied for bone and joint and propose methods that can be promising in clinical use. Frontiers Media S.A. 2020-11-19 /pmc/articles/PMC7711090/ /pubmed/33330428 http://dx.doi.org/10.3389/fbioe.2020.598466 Text en Copyright © 2020 Gantenbein, Tang, Guerrero, Higuita-Castro, Salazar-Puerta, Croft, Gazdhar and Purmessur. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Gantenbein, Benjamin
Tang, Shirley
Guerrero, Julien
Higuita-Castro, Natalia
Salazar-Puerta, Ana I.
Croft, Andreas S.
Gazdhar, Amiq
Purmessur, Devina
Non-viral Gene Delivery Methods for Bone and Joints
title Non-viral Gene Delivery Methods for Bone and Joints
title_full Non-viral Gene Delivery Methods for Bone and Joints
title_fullStr Non-viral Gene Delivery Methods for Bone and Joints
title_full_unstemmed Non-viral Gene Delivery Methods for Bone and Joints
title_short Non-viral Gene Delivery Methods for Bone and Joints
title_sort non-viral gene delivery methods for bone and joints
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711090/
https://www.ncbi.nlm.nih.gov/pubmed/33330428
http://dx.doi.org/10.3389/fbioe.2020.598466
work_keys_str_mv AT gantenbeinbenjamin nonviralgenedeliverymethodsforboneandjoints
AT tangshirley nonviralgenedeliverymethodsforboneandjoints
AT guerrerojulien nonviralgenedeliverymethodsforboneandjoints
AT higuitacastronatalia nonviralgenedeliverymethodsforboneandjoints
AT salazarpuertaanai nonviralgenedeliverymethodsforboneandjoints
AT croftandreass nonviralgenedeliverymethodsforboneandjoints
AT gazdharamiq nonviralgenedeliverymethodsforboneandjoints
AT purmessurdevina nonviralgenedeliverymethodsforboneandjoints